Home/Filings/4/0001790340-24-000008
4//SEC Filing

Hall Brett Matthew 4

Accession 0001790340-24-000008

CIK 0001790340other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:12 PM ET

Size

5.4 KB

Accession

0001790340-24-000008

Insider Transaction Report

Form 4
Period: 2024-02-08
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option

    2024-02-08+130,900130,900 total
    Exercise: $6.09Exp: 2034-02-08Class A Common Stock (130,900 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001870437

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:12 PM ET
Size
5.4 KB